Order Article Reprints

Mikhailova E, Illarionova O, Komkov A, Zerkalenkova E, Mamedov I, Shelikhova L, Olshanskaya Y, Miakova N, Novichkova G, Karachunskiy A, et al. Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy. Cancers. 2022; 14(21):5445. https://doi.org/10.3390/cancers14215445

Mikhailova, Ekaterina, Olga Illarionova, Alexander Komkov, Elena Zerkalenkova, Ilgar Mamedov, Larisa Shelikhova, Yulia Olshanskaya, Natalia Miakova, Galina Novichkova, Alexander Karachunskiy, and et al. 2022. "Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy" Cancers 14, no. 21: 5445. https://doi.org/10.3390/cancers14215445

Mikhailova, E., Illarionova, O., Komkov, A., Zerkalenkova, E., Mamedov, I., Shelikhova, L., Olshanskaya, Y., Miakova, N., Novichkova, G., Karachunskiy, A., Maschan, M., & Popov, A. (2022). Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy. Cancers, 14(21), 5445. https://doi.org/10.3390/cancers14215445